TEOSYAL/TEOXANE

TEOSYAL INJECTABLE : TEOSYAL DERMAL FILLER

TEOXANE Laboratories develop and produce different ranges of hyaluronic acid based dermal fillers, designed to compensate volume lost during the ageing process.

TEOSYAL is 100% based on hyaluronic acid. It is a product of non-animal, biodegradable and resorbable.

Is an exclusive range of wrinkle fillers based on hyaluronic acid injectable form.

With TEOSYAL® range, it is possible to redefine the lines and redraw the contours of your face in the most gentle way and most natural possible.

LA TRIPLE ACTION TEOSYAL

1 /Bridging: Injection under the wrinkle to lift from the inside to make it disappear instantly thanks to the volume created.

2 /Lifter: Lifting effect and immediate volumizer.

3 /Hydrate: Hyaluronic acid is able to hold up to 1000 times its weight in water. Deep hydration of the skin. Respect for the flexibility of the tissues to make the result totally effective and natural.

Biocompatible and slow-resorption products.

NEW BOX 2018

SUBLIMATEURS SKIN QUALITY

REDENSITY I PureSense Redensity [I] non réticulé 15 mg/g  3x1 ml ou 2x1 ml 

Designed for the prevention of wrinkles and rehydration of the face, neck and neckline.

MESO AH non réticulé -15 mg/ml 

Designed for skin revitalisation and rehydration13 (Face - Neck - Décolleté)

ESSENTIELS BASICS

FIRST LINE 20 mg/g - Réticulé 1/5 - 2 x 0,7 ml 

Correction des rides superficielles.

TOUCH UP 25 mg/g - Réticulé 3/5 - 2 x 0,5 ml 

Final touch

GLOBAL 25 mg/g - Réticulé 3/5 - 2 x 1 ml 

For the treatment of moderate lines/wrinkles, cutaneous depressions, nasolabial folds and the glabella.

DEEP 25 mg/g - Réticulé 3/5 - 2 x 1 ml 

For the treatment of deep lines/wrinkles, nasolabial folds and the marionette lines.

THE VOLUMIZERS

ULTRA DEEP  

25 mg/g - Réticulé 4/5 - 2 x 1,2 ml 

To build or restore volume in areas like the cheekbones and chin.

ULTIMATE 

22 mg/g -Réticulé 5/5 -2 x 1 ml 

Designed for the volume recovery of wide areas (Cheekbones - Chin - Jawline - Temples)

THE SPECIFICS

REDENSITY II   PureSense Redensity [II]  -AH Semi-réticulé 15 mg/g  -2 x 1 ml -

Designed for under-eye correction6 and tear trough treatment.

KISS 25 mg/g -Réticulé 4/5 -2 x 1 ml

Specifically created for lip enhancement and lip contour.

With TEOSYAL®RHA, hyaluronic acid is going through an innovative manufacturing process, in order to create the first resilient hyaluronic acid dedicated to facial dynamism.

TEOSYAL® RHA (Resilient Hyaluronic Acid) 

RHA 1: THE DYNAMICS 

Superficial and fine wrinkles- Hyaluronic acid concentration (mg/mL) : 15

RHA 2:  THE DYNAMICS 

Moderate wrinkles- Hyaluronic acid concentration (mg/mL) : 23

For the treatment of moderate wrinkles on the upper face: glabella, forehead and crow’s feet or to add volume to the lips and/or enhance their contour.

TEOSYAL RHA® 2 exists also without lips indication.

RHA 3:  THE DYNAMICS 

Deep wrinkles- Hyaluronic acid concentration (mg/mL) : 23

For the treatment of deep wrinkles on the face, such as nasogenian folds, vertical lip lines, deep lines and creases, cheek augmentation and to restore the shape of the face.

TEOSYAL RHA® 3 exists also without lips indication.

RHA 4: THE VOLUMIZERS

Volume in extended areas - Hyaluronic acid concentration (mg/mL) : 23

Designed to provide volume in dynamic extended areas such as the cheeks and facial contours.

SKINCARE TEOXANE GAMME COSMECEUTICALS

Cosmeceuticals' skincare line has the same crossed-linked hyaluronic acid used in our dermal-filler injections.More than the recognized properties of traditional Hyaluronic Acid, our patented RHA Resilient Hyaluronic Acid®  forms a mesh on the application zone that permits active ingredients to gradually be released.

Balancing the codes of premium skincare with the rigor of medical science, Teoxane Cosmeceuticals is an innovative skincare line perfectly adapted and complementary to advanced esthetic procedures.

PROFESSIONAL RANGE USE IN MEDICAL CABINET AS NEED FOR A MEDICAL ACT CARRIED OUT BY A SPECIALIZED DOCTOR, DERMATOLOGIST OR AESTHETIC MEDICINE.